ArticleProceedings (Baylor University. Medical Center)2025

Breaking the storm: ruxolitinib as a lifeline in refractory hemophagocytic lymphohistiocytosis with macrophage activation syndrome.

Tomas Escobar Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.